Anzeige
Mehr »
Mittwoch, 26.11.2025 - Börsentäglich über 12.000 News
Kupfer-Superzyklus voraus: Dieses Top-Projekt in Nevada wird jetzt zum echten Investmentcase
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2G832 | ISIN: CA92663R1055 | Ticker-Symbol: VIJ
Frankfurt
26.11.25 | 08:03
5,750 Euro
+1,77 % +0,100
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
VIEMED HEALTHCARE INC Chart 1 Jahr
5-Tage-Chart
VIEMED HEALTHCARE INC 5-Tage-Chart
RealtimeGeldBriefZeit
5,8006,40013:24

Aktuelle News zur VIEMED HEALTHCARE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
06.11.Viemed Healthcare misses top-line and bottom-line estimates; narrows FY25 revenue outlook4
05.11.Viemed Healthcare, Inc.: Viemed Healthcare Announces Third Quarter 2025 Financial Results279LAFAYETTE, LA / ACCESS Newswire / November 5, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment...
► Artikel lesen
05.11.VIEMED HEALTHCARE, INC. - 10-Q, Quarterly Report-
05.11.VIEMED HEALTHCARE, INC. - 8-K, Current Report-
05.11.Viemed Healthcare Q3 Earnings Preview2
04.11.Viemed Healthcare's Earnings: A Preview1
22.10.Viemed Healthcare, Inc.: Viemed Healthcare Announces Third Quarter 2025 Earnings Conference Call Details330LAFAYETTE, LA / ACCESS Newswire / October 21, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today...
► Artikel lesen
14.10.Viemed Healthcare, Inc. to Present at the LD Micro Main Event XIX253Lafayette, Louisiana--(Newsfile Corp. - October 14, 2025) - Viemed Healthcare, Inc. (NASDAQ: VMD), a national leader of in-home, technology-enabled post-acute respiratory care, announced today that...
► Artikel lesen
VIEMED HEALTHCARE Aktie jetzt für 0€ handeln
23.09.Viemed completes $13.2 million share repurchase program3
23.09.Viemed Healthcare, Inc.: Viemed Healthcare Announces Completion of Share Repurchase Program321LAFAYETTE, LA / ACCESS Newswire / September 23, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care...
► Artikel lesen
23.09.VIEMED HEALTHCARE, INC. - 8-K, Current Report4
12.08.VIEMED HEALTHCARE, INC. - S-8, Securities to be offered to employees in employee benefit plans2
07.08.Viemed Healthcare reports Q2 results2
06.08.VIEMED HEALTHCARE, INC. - 10-Q, Quarterly Report1
06.08.VIEMED HEALTHCARE, INC. - 8-K, Current Report2
06.08.Viemed Healthcare, Inc.: Viemed Healthcare Announces Second Quarter 2025 Financial Results414LAFAYETTE, LA / ACCESS Newswire / August 6, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment...
► Artikel lesen
22.07.Viemed Healthcare, Inc.: Viemed Healthcare Announces Second Quarter 2025 Earnings Conference Call Details214LAFAYETTE, LA / ACCESS Newswire / July 22, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and...
► Artikel lesen
02.07.Viemed to lift outlook as Lehan's acquisition completes1
02.07.VIEMED HEALTHCARE, INC. - 8-K, Current Report3
02.07.Viemed Healthcare, Inc.: Viemed Completes Acquisition of Lehan's Medical Equipment Anticipates Updating its Full Year 2025 Outlook for the Acquisition with Second Quarter 2025 Financial Results341LAFAYETTE, LA / ACCESS Newswire / July 2, 2025 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and...
► Artikel lesen
Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1